• 1
    Matsuzaki J, Torogoe T, Hirohashi Y et al. ECRG4 is a novel inhibitor of Fas-induced apoptosis in human T-leukemia cells. Carcinogenesis 2012; 33: 9961003.
  • 2
    Su T, Liu H, Lu S. Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi 1998; 20: 254257 [in Chinese].
  • 3
    Yue CM, Deng DJ, Bi MX, Guo LP, Lu SH. Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9: 11741178.
  • 4
    Götze S, Feldhaus V, Traska T et al. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 2009; 9: 447.
  • 5
    Vanaja DK, Ehrich M, Van den Boom D et al. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest 2009; 27: 549560.
  • 6
    Li W, Liu X, Zhang B et al. Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion. J Exp Clin Cancer Res 2010; 29: 17.
  • 7
    Kujuro Y, Suzuki N, Kondo T. Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc Natl Acad Sci U S A 2010; 107: 82598264.
  • 8
    Li LW, Yu XY, Yang Y, Zhang CP, Guo LP, Lu SH. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer 2009; 125: 15051513.
  • 9
    Takahashi S, Sato N, Takayama S et al. Establishment of apoptosis-inducing monoclonal antibody 2D1 and 2D1-resistant variants of human T cell lines. Eur J Immunol 1993; 23: 19351941.
  • 10
    Inoda S, Hirohashi Y, Torigoe T et al. Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. J Immunother 2009; 32: 474485.
  • 11
    Asanuma H, Torigoe T, Kamiguchi K et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res 2005; 65: 1101811025.
  • 12
    Mori Y, Ishiguro H, Kuwabara Y et al. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep 2007; 18: 981985.
  • 13
    Bashash M, Hislop TG, Shah AM, Le N, Brooks-Wilson A, Bajdik CD. The prognostic effect of ethnicity for gastric and esophageal cancer: The population-based experience in British Columbia, Canada. BMC Cancer 2011; 11: 164.
  • 14
    Bhoo-Pathy N, Hartman M, Yip CH et al. Ethnic differences in survival after breast cancer in South East Asia. PLoS One 2012; 7: e30995.